Filtered By:
Source: Journal of Stroke and Cerebrovascular Diseases
Condition: Atrial Fibrillation
This page shows you your search results in order of relevance. This is page number 18.
Order by Relevance | Date
Total 320 results found since Jan 2013.
Therapeutic Decisions in Atrial Fibrillation for Stroke Prevention: The Role of Aversion to Ambiguity and Physicians' Risk Preferences
Knowledge-to-action gaps influence therapeutic decisions in atrial fibrillation (AF). Physician-related factors are common, but the least studied. We evaluated the prevalence and determinants of physician-related factors and knowledge-to-action gaps among physicians involved in the management of AF patients.
Source: Journal of Stroke and Cerebrovascular Diseases - April 9, 2018 Category: Neurology Authors: Luciano A. Sposato, Devin Stirling, Gustavo Saposnik Source Type: research
Clinical Outcomes of Valvular versus Nonvalvular Atrial Fibrillation in Acute Anterior Circulation Occlusive Stroke Undergoing Endovascular Treatment
Thrombectomy is the first choice for cardioembolism due to atrial fibrillation (AF), however, whether valvular AF and nonvalvular AF had different safety and functional outcomes has not been reported yet. We aimed to investigate the differences between patients with valvular AF and patients with nonvalvular AF on safety and functional outcomes in acute large artery occlusion undergoing thrombectomy.
Source: Journal of Stroke and Cerebrovascular Diseases - October 3, 2018 Category: Neurology Authors: Wenchen Li, Shang Wang, Shijun Li, Xin Chen, Yunyun Xiong Source Type: research
Hemorrhagic Transformation After Acute Ischemic Stroke in Atrial Fibrillation Patients
We read with interest the study by Ge, Wan-Qian et al.1 One of the results from the study was that the risk of hemorrhagic transformation (HT) was higher in patients with atrial fibrillation (AF).
Source: Journal of Stroke and Cerebrovascular Diseases - October 26, 2018 Category: Neurology Authors: George K. Vilanilam, Mohammed K. Badi, Bhavya Yarlagadda, Lela Okromelidze Source Type: research
Atrial Fibrillation: An Underestimated Cause of Ischemic Monocular Visual Loss?
Introduction: Atrial fibrillation (AF) is a major cause of ischemic stroke and Transient Ischemic Attack (TIA) and investigation for paroxysmal AF is recommended following an embolic brain event. In contrast, retinal ischemic monocular blindness is traditionally considered most linked to carotid artery disease (CAS) and investigating for AF is less vigilant. We aimed to determine the prevalence of AF in patients with ischemic monocular blindness. Methods: Consecutive records of all patients presenting to a daily TIA clinic with transient or permanent ischemic monocular blindness were reviewed, January 2014-October 2016.
Source: Journal of Stroke and Cerebrovascular Diseases - March 28, 2019 Category: Neurology Authors: Angeliki Zarkali, Suk Fun Cheng, Agnes Dados, Robert Simister, Arvind Chandratheva Source Type: research
Pharmacotherapy for Patients With Atrial Fibrillation and Cerebral Microbleeds
Background: Patients with cerebral microbleeds have increased risk of intracranial hemorrhage and ischemic stroke. No trial specifically informs antithrombotic therapy for patients with cerebral microbleeds and atrial fibrillation. We investigated the safety of anticoagulation versus no anticoagulation with regard to cerebrovascular outcomes and mortality. Methods: All consecutive atrial fibrillation patients from 2015 to 2018 with MRI evidence of ≥1 cerebral microbleed at time of imaging were reviewed.
Source: Journal of Stroke and Cerebrovascular Diseases - May 14, 2019 Category: Neurology Authors: Mohammed K. Badi, George K. Vilanilam, Vivek Gupta, Kevin M. Barrett, Elizabeth R. Lesser, Jordan J. Cochuyt, David O. Hodge, Thomas G. Brott, James F. Meschia Source Type: research
Clinical Risk Factors of Thromboembolic and Major Bleeding Events for Patients with Atrial Fibrillation Treated with Rivaroxaban in Japan
Background: It is important to understand the risk of thromboembolism and bleeding in patients with nonvalvular atrial fibrillation (NVAF) receiving direct oral anticoagulants; however, data on risk factors in Japanese patients are limited. Methods: XAPASS (Xarelto Post-Authorization Safety and Effectiveness Study in Japanese Patients with Atrial Fibrillation) is a prospective observational study examining the safety and effectiveness of rivaroxaban in Japanese real-world clinical practice. We investigated risk factors for stroke/noncentral nervous system systemic embolism (non-CNS SE)/myocardial infarction (MI) and major ...
Source: Journal of Stroke and Cerebrovascular Diseases - January 22, 2020 Category: Neurology Authors: Susumu Miyamoto, Takanori Ikeda, Satoshi Ogawa, Takanari Kitazono, Jyoji Nakagawara, Kazuo Minematsu, Yuji Murakawa, Sanghun Iwashiro, Makiko Takeichi, Yoko Kidani, Yutaka Okayama, Toshiyuki Sunaya, Shoichiro Sato, Satoshi Yamanaka Source Type: research
Predictive Markers of Atrial Fibrillation in Patients with Transient Ischemic Attack
Background: Atrial fibrillation (AF) is a major cause of cardio-embolism in patients with stroke and transient ischemic attack (TIA). Insertable cardiac monitors (ICM) make long-term monitoring for AF possible, but limited health care resources make patient selection important. AF is associated with atherosclerosis and markers of this could potentially be used to guide AF monitoring. Methods and Results: One-hundred fourteen TIA-patients without AF were thoroughly monitored for AF with ECG, 72-hour Holter monitoring and ICM with a median monitoring time of 2.2 years.
Source: Journal of Stroke and Cerebrovascular Diseases - January 28, 2020 Category: Neurology Authors: Kenneth Bruun Pedersen, Charlotte Madsen, Niels C.F. Sandgaard, Axel C.P. Diederichsen, S øren Bak, Mads Nybo, Axel Brandes Source Type: research
Acute Thrombocytopenia After Tissue Plasminogen Activator for Stroke
An 88 year-old right-handed female with a history of atrial fibrillation presented with acute onset left-sided weakness, forced rightward gaze deviation, and neglect. She was found to have a right M1 occlusion and a favorable penumbra on CT Perfusion. She received 0.9 mg/kg (52.77 mg) of tPA with a 10% (5.27 mg) bolus given over the first minute. She was taken for thrombectomy with Thrombolysis in Cerebral Infarction (TICI) IIb revascularization. She received 1200 mL of heparin during thrombectomy.
Source: Journal of Stroke and Cerebrovascular Diseases - May 10, 2020 Category: Neurology Authors: Jonathan Morena, Casey May, Tamara Strohm Tags: Case Report Source Type: research
Analysis of Risk Factors Independently Associated with Cognitive Impairment in Patients with Permanent Atrial Fibrillation: A Cross-sectional Observational Study
Atrial Fibrillation (AF) is associated with an increased risk of stroke and development of cognitive impairment. Our cross-sectional study aims to identify risk factors for cognitive impairment in patients with permanent AF.
Source: Journal of Stroke and Cerebrovascular Diseases - May 16, 2020 Category: Neurology Authors: Renata Petroni, Roberta Magnano, Laura Pezzi, Angelo Petroni, Michele Di Mauro, Antonella Mattei, Fabiana Fiasca, Anna Maria Angelone, Sabina Gallina, Maria Penco, Silvio Romano Source Type: research
Dabigatran-induced chronic progressive immune hemolytic anemia: A case report
We present a case of immune hemolytic anemia (IHA) due to dabigatran use in a 72-year-old male with NVAF.
Source: Journal of Stroke and Cerebrovascular Diseases - July 15, 2020 Category: Neurology Authors: Jin-Hong Gong, Guang-Jun Liu, Feng Zhou, Zhi-Qiang Sun Tags: Case Report Source Type: research
Left Atrial Spinning Ball Thrombus in a Patient with Cardioembolic Stroke: A Case Report
Left atrial thrombi are found in 2.5 –18% of patients with atrial fibrillation and are the main cause of thromboembolic events.1 Abe et al advocated the classification of left atrial thrombi into three types; movable ball type, fixed ball type and mountain type, and demonstrated that the rate of embolism in the movable type group wa s significantly higher than that in the other groups.2,3 However, there is no previous report that specifically describes what kind of movement has a poor prognosis in movable left atrial thrombi.
Source: Journal of Stroke and Cerebrovascular Diseases - October 3, 2020 Category: Neurology Authors: Akira Machida, Yasuhito Kawana, Itsuki Soejima, Takeshi Bo, Eiichiro Amano Tags: Case Report Source Type: research
Emergency Medicine Physician Attitudes toward Anticoagulant Initiation for Patients with Atrial Fibrillation
Guidelines for the primary prevention of stroke recognize the emergency department as a location for physicians to identify atrial fibrillation and to initiate oral anticoagulants. Numerous studies have shown low anticoagulant prescription rates —approximately 18%—in OAC-naïve patients with atrial fibrillation discharged from the emergency department. We sought to obtain the opinions of Emergency Medicine physicians regarding anticoagulant decision-making for patients with atrial fibrillation seen in the emergency department.
Source: Journal of Stroke and Cerebrovascular Diseases - November 24, 2020 Category: Neurology Authors: Hope Hua, Nicole Sur, Lilly Lee, Seemant Chaturvedi Source Type: research
Determination of Cerebrovascular Accident Predictors in Patients with New-Onset Atrial Fibrillation After Coronary Artery Bypass Graft Surgery
Postoperative atrial fibrillation (POAF) is associated with an increased risk of short and long-term stroke. Our aim is to identify the independent predictors of cerebrovascular accident (CVA) development in the patients who underwent isolated coronary artery bypass graft (CABG) surgery and developed POAF which lasted within 48 h.
Source: Journal of Stroke and Cerebrovascular Diseases - January 12, 2021 Category: Neurology Authors: Ali Riza Demir, Omer Celik, Begum Uygur, Mustafa Umut Somuncu, Emre Yilmaz, Yalcin Avci, Muhammed Bayram, Mehmet Erturk Source Type: research
Malignant Left Atrial Appendage Morphology: Current Classification vs H-L System
In non-valvular atrial fibrillation (AF), more than 90% of thrombus formation occurs in the left atrial appendage (LAA).1-3 Current guidelines have established direct oral anticoagulants (DOACs) as the treatment of choice in patients with AF and high risk of stroke or transient ischemic attack (TIA), while vitamin K antagonists (VKA) can be considered in patients not suitable for DOACs.4,5 This strategy significantly reduces the risk of thromboembolism; however, there is a subset of patients that suffer recurrent embolic strokes despite appropriate anticoagulant therapy, known as malignant LAA.
Source: Journal of Stroke and Cerebrovascular Diseases - December 30, 2020 Category: Neurology Authors: Paloma Parra-D íaz, Luisa Salido-Tahoces, Ana Pardo-Sanz, Álvaro Beltrán-Corbellini, Fernando Rodríguez-Jorge, Juan Luis Chico-García, Sebastián García-Madrona, Consuelo Matute-Lozano, Rocío Vera-Lechuga, Antonio Cruz-Culebras, Jaime Masjuan, Alic Source Type: research
